Clinical trial
Hypertension and Cardiovascular Risk Factors
NCT00171782 · Novartis, Industry · Completed
Key facts
| NCT number | NCT00171782 |
|---|---|
| Title | Hypertension and Cardiovascular Risk Factors |
| Official title | Valsartan Plus Hydrochlorothiazide in Patients With Hypertension and Cardiovascular Risk Factors |
| Lead sponsor | Novartis, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | HYPERTENSION |
| Intervention type | Drug |
| Interventions | VALSARTAN+HYDROCHLOROTHIAZIDE |
| Enrollment | 76 |
| Start date | Feb 1, 2004 |
| Primary completion | Dec 1, 2004 |
| Completion | Dec 1, 2004 |
| First posted | Sep 15, 2005 |
| Last update posted | Oct 12, 2023 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: